Thursday, 30 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > U.S. adult obesity rate fell in 2023, as use of GLP-1 meds rose
Health and Wellness

U.S. adult obesity rate fell in 2023, as use of GLP-1 meds rose

Last updated: December 13, 2024 5:08 pm
Share
U.S. adult obesity rate fell in 2023, as use of GLP-1 meds rose
SHARE

The findings showed that the obesity rate in the United States decreased from 46.2% in 2021 to 45.6% in 2023. This marks the first decline in the obesity rate in a decade, a significant milestone in the ongoing battle against obesity in the country.

The study, conducted by researchers at Harvard University, analyzed data on almost 17 million adults nationwide. Obesity was defined as having a body mass index (BMI) of 30 or above. The researchers noted that the most significant decrease in obesity was observed in the South, which also had the highest dispensing rate of GLP-1 medications.

GLP-1 medications, such as Wegovy and Zepbound, have seen a surge in use in recent years. These medications have been associated with weight loss, although the researchers cautioned that it is not possible to confirm a cause-and-effect relationship between the decline in obesity rates and the increased use of these medications.

The study, led by Benjamin Rader, an assistant professor of anesthesia at Harvard Medical School, was published in the journal JAMA Health Forum. Rader and his team highlighted the long-standing issue of rising obesity rates in the U.S. and the conflicting forecasts about whether this trend will continue or plateau.

The introduction of GLP-1 medications into the market has introduced a new factor in the fight against obesity. These medications, which mimic a hormone in the intestine that helps regulate appetite, have shown promising results in terms of weight loss. Sales of these medications have soared in recent years, and many individuals have experienced significant weight loss as a result.

See also  On World AIDS Day, a celebration of progress but continued uncertainty

The study tracked health insurance data from 2013 through 2023 and focused on adults between the ages of 26 and 75. While the researchers were unable to definitively establish a causal relationship between the decline in obesity rates and the use of GLP-1 medications, the findings suggest that these medications may play a role in addressing the obesity epidemic in the U.S.

Overall, the study provides valuable insights into the complex factors influencing obesity rates in the U.S. and underscores the need for continued research and intervention to combat this ongoing public health challenge.

TAGGED:AdultfellGLP1MedsObesityrateRoseU.S
Share This Article
Twitter Email Copy Link Print
Previous Article Build a website in record time with Squarespace Build a website in record time with Squarespace
Next Article A BROTHERS’ WAR: Unforgiving Prince William Still EXTREMELY Angry With Prodigal Brother Harry, Who Is NOT Invited to the Windsor’s Christmas Celebration in Sandringham | A BROTHERS’ WAR: Unforgiving Prince William Still EXTREMELY Angry With Prodigal Brother Harry, Who Is NOT Invited to the Windsor’s Christmas Celebration in Sandringham |
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Moki Cherry, the Swedish Designer Who Blurred Art and Life 

The Fabric Workshop and Museum (FWM) in Philadelphia is gearing up to host a retrospective…

July 8, 2025

Inside the 2025 Grammy Awards: Celeb Photos, Moments You Didn’t See

The 2025 Grammy Awards brought together the biggest names in music for a night of…

February 3, 2025

Elevance stock tumbles on 3Q results, Medicaid costs

Medicaid remains a crucial lifeline for many individuals who rely on it for access to…

October 19, 2024

Tina Knowles’ Memoir Event Interrupted by Wardrobe Malfunction

Tina Knowles experienced a wardrobe malfunction at an event for her new book, "Matriarch: A…

May 4, 2025

Lennar Corporation (LEN) Stock Forecasts

Lennar Corp: A Leading Homebuilder in the United States Summary Lennar Corp, headquartered in Miami,…

March 28, 2025

You Might Also Like

Hydrogen gas found to play key role in supporting gut health
Health and Wellness

Hydrogen gas found to play key role in supporting gut health

October 30, 2025
Alignment Healthcare Reports Second Profitable Quarter By Taming Costs
Health and Wellness

Alignment Healthcare Reports Second Profitable Quarter By Taming Costs

October 30, 2025
Blue Cross’ new algorithm for health care costs infuriates doctors
Health and Wellness

Blue Cross’ new algorithm for health care costs infuriates doctors

October 30, 2025
Eating patterns may be more closely tied to seasonal rhythms than previously thought
Health and Wellness

Eating patterns may be more closely tied to seasonal rhythms than previously thought

October 30, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?